RELMADA THERAPEUTICS (RLMD) stock: insider trades, news & valuation
Health Care · Strong buyingShare price and insider trades
RELMADA THERAPEUTICS insider trading at a glance (Oct 9, 2026): in the past 12 months, 4 insiders bought $4.0M and 0 sold $0 of RLMD stock on the open market, including a cluster buy that began Nov 5, 2025.
Get emailed when insiders cluster-buy stocks like RLMD
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
RLMD insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | $1.7M | 4 | — | 0 |
| Q2 2026 | — | 0 | — | 0 |
| Q1 2026 | — | 0 | — | 0 |
| Q4 2025 | $2.4M | 6 | — | 0 |
Valuation, profit and volume
Pick score 62/100Summary
Over the past 12 months, 4 RELMADA THERAPEUTICS, INC. insiders reported open-market purchases totaling $4.0M, while 0 insiders reported sales totaling $0. The most recent cluster buy began on Nov 5, 2025, when 4 insiders bought a combined $2.2M. Among insiders with enough purchase history to measure, Maged Shenouda (CFO) has the highest Insider Score at 93.
RLMD stock news and SEC filings
Recent 8-K filings and headlines. Tone is scored from the headline wording; “Policy” marks regulatory, trade or government topics.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Sep 11SEC | Maged ShenoudaCFO | Buy | 120,200920,200 held (+15%) | $4.20 | $505K | -19.3% | 93 |
| Sep 11SEC | Sergio TraversaCEO | Buy | 100,0001,400,000 held (+8%) | $4.18 | $418K | -18.9% | 93 |
| Sep 11SEC | Sergio TraversaCEO | Buy | 100,0001,500,000 held (+7%) | $4.10 | $410K | -17.3% | 93 |
| Sep 11SEC | Maged ShenoudaCFO | Buy | 79,8001,000,000 held (+9%) | $4.25 | $339K | -20.2% | 93 |
| Dec 16SEC | Sergio TraversaCEO | Buy | 27,5001,300,000 held (+2%) | $4.12 | $113K | -17.7% | 93 |
| Dec 16SEC | Maged ShenoudaCFO | Buy | 11,665800,000 held (+1%) | $4.12 | $48K | -17.7% | 93 |
| Nov 6SEC | Maged ShenoudaCFO | Buy | 500,000788,335 held (+173%) | $2.20 | $1.1M | +54.1% | 93 |
| Nov 6SEC | Sergio TraversaCEO | Buy | 272,5001,272,500 held (+27%) | $2.20 | $600K | +54.1% | 93 |
| Nov 6SEC | Chuck EnceCOO | Buy | 136,000403,931 held (+51%) | $2.20 | $299K | +54.1% | — |
| Nov 6SEC | Paul Edward KellyCOO | Buy | 90,000502,295 held (+22%) | $2.20 | $198K | +54.1% | — |
Insiders at RELMADA THERAPEUTICS, INC.
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Maged ShenoudaCFO | $2.0M | — | Sep 11, 2026 | 93 |
| Sergio TraversaCEO | $1.5M | — | Sep 11, 2026 | 93 |
| Chuck EnceCOO | $299K | — | Nov 6, 2025 | — |
| Paul Edward KellyCOO | $198K | — | Nov 6, 2025 | — |
Insider activity at other Health Care companies
Same sector, ranked by insider buying in the last 90 days.
RLMD stock: common questions
Are RELMADA THERAPEUTICS, INC. insiders buying RLMD stock?
In the past 12 months, 4 insiders reported open-market purchases of RLMD worth $4.0M. The latest was CFO Maged Shenouda bought $505K of RLMD at $4.20.
Are RELMADA THERAPEUTICS, INC. insiders selling RLMD stock?
0 insiders reported sales worth $0 over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is RLMD's 52-week range?
Over the past year RLMD has traded between $1.93 and $7.86. It last closed at $3.39 on Oct 9, 2026.